Blackford Partnership to Enhance Decision Support for Chest and Head Pathologies

Update: Harrison.ai Radiology solutions were previously marketed as Annalise.ai

Edinburgh, Scotland, April 23, 2024 – Blackford, the pioneering strategic AI platform and solutions provider, and annalise.ai, a leading provider of radiology AI solutions, today announced a commercial partnership to bring Annalise’s CXR and CTB solutions to healthcare providers in EMEA via the Blackford Platform.  

Blackford provides healthcare professionals access to an extensive portfolio of more than 120 AI solutions designed to drive clinical accuracy and efficiency and improve patient outcomes. Integrating annalise.ai’s advanced comprehensive technology into the Blackford Platform equips healthcare providers with potent tools for detecting multiple pathologies in chest X-rays and head CT scans.  

“We’re delighted to join forces with annalise.ai,” says Ben Panter, Founder and CEO of Blackford. “Their commitment to supporting clinical decision-making resonates deeply with our vision of revolutionising healthcare through AI. By integrating their comprehensive applications into our platform, we are expanding the breadth and depth of AI solutions available to healthcare providers to help support the advancement of public health.”  

Annalise’s comprehensive solutions can detect up to 124 findings on chest radiographs and up to 130 findings on non-contrast head CTs. It helps radiologists by flagging, highlighting, and ordering cases based on different priority groups. Configurable worklist priority categories, such as ‘critical,’ ‘high,’ ‘low,’ ‘unremarkable,’ or ‘no abnormality detected,’ empower clinicians to efficiently triage cases. The ability to assign unremarkable priority groups for cases with no or unremarkable findings streamlines reporting efficiency and accelerates turnaround times for critical cases. The solutions also create draft reports that clinicians can verify and sign off thereby saving time for clinicians*. 

“We are excited to embark on this collaborative journey with Blackford, a leader in the radiology AI space. This partnership is a significant step forward in our mission to empower radiologists with cutting-edge AI tools,” commented Dimitry Tran, Co-founder and Deputy CEO at annalise.ai.    

This strategic partnership underscores the commitment of both Blackford and annalise.ai to advancing healthcare solutions through the integration of state-of-the-art AI technologies. The collective goal is to bring about positive transformations in clinical workflows, enhance reporting efficiency, and ultimately improve patient care.   

* ~35% of CXR and CTB cases supported today (April 2024) will have a complete, editable radiology report.. 

About Blackford 

Blackford are pioneers in the radiology AI space, with over a decade of experience working in partnership with leading hospitals and ground-breaking technology providers. We operate as a strategic AI partner, providing access to a tried-and-tested core platform, tailored services, and a portfolio of 120+ applications to help healthcare providers unlock the value of AI and improve patient outcomes.  

Our collaboration and recent arms-length acquisition by Bayer ensures that our customers and partners have the support and long-term security needed to underpin successful AI strategies. 

To learn more about Blackford’s tailored approach to AI solutions visit www.blackfordanalysis.com, and follow us on X and LinkedIn.